Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Viridian Therapeutics, Inc.\DE (VRDN) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Viridian Therapeutics, Inc.\DE (VRDN) over the last 9 years, with Q3 2025 value amounting to 0.04.

  • Viridian Therapeutics, Inc.\DE's Debt Ratio rose 3613.79% to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year increase of 3613.79%. This contributed to the annual value of 0.03 for FY2024, which is 3270.84% down from last year.
  • According to the latest figures from Q3 2025, Viridian Therapeutics, Inc.\DE's Debt Ratio is 0.04, which was up 3613.79% from 0.04 recorded in Q2 2025.
  • Viridian Therapeutics, Inc.\DE's 5-year Debt Ratio high stood at 0.04 for Q4 2023, and its period low was 0.03 during Q3 2024.
  • Moreover, its 3-year median value for Debt Ratio was 0.03 (2024), whereas its average is 0.03.
  • Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Debt Ratio plummeted by 3270.84% in 2024 and then soared by 3613.79% in 2025.
  • Viridian Therapeutics, Inc.\DE's Debt Ratio (Quarter) stood at 0.04 in 2023, then crashed by 32.71% to 0.03 in 2024, then surged by 30.56% to 0.04 in 2025.
  • Its Debt Ratio stands at 0.04 for Q3 2025, versus 0.04 for Q2 2025 and 0.03 for Q1 2025.